Unknown

Dataset Information

0

Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.


ABSTRACT: Prostaglandin (PG) E2 exhibits an anti-fibrotic effect in the lung in response to inflammatory reactions and is a high-affinity substrate of PG transporter (SLCO2A1). The present study aimed to evaluate the pathophysiological relevance of SLCO2A1 to bleomycin (BLM)-induced pulmonary fibrosis in mice. Immunohistochemical analysis indicated that Slco2a1 protein was expressed in airway and alveolar type I (ATI) and II (ATII) epithelial cells, and electron-microscopic immunohistochemistry further demonstrated cell surface expression of Slco2a1 in ATI cells in wild type (WT) C57BL/6 mice. PGE2 uptake activity was abrogated in ATI-like cells from Slco2a1-deficient (Slco2a1-/-) mice, which was clearly observed in the cells from WT mice. Furthermore, the PGE2 concentrations in lung tissues were lower in Slco2a1-/- than in WT mice. The pathological relevance of SLCO2A1 was further studied in mouse BLM-induced pulmonary fibrosis models. BLM (1 mg/kg) or vehicle (phosphate buffered saline) was intratracheally injected into WT and Slco2a1-/- mice, and BLM-induced fibrosis was evaluated on day 14. BLM induced more severe fibrosis in Slco2a1-/- than in WT mice, as indicated by thickened interstitial connective tissue and enhanced collagen deposition. PGE2 levels were higher in bronchoalveolar lavage fluid, but lower in lung tissues of Slco2a1-/- mice. Transcriptional upregulation of TGF-?1 was associated with enhanced gene transcriptions of downstream targets including plasminogen activator inhitor-1. Furthermore, Western blot analysis demonstrated a significant activation of protein kinase C (PKC) ? along with a modest activation of Smad3 in lung from Slco2a1-/- mice, suggesting a role of PKC? associated with TGF-? signaling in aggravated fibrosis in BLM-treated Slco2a1-/- mice. In conclusion, pulmonary PGE2 disposition is largely regulated by SLCO2A1, demonstrating that SLCO2A1 plays a critical role in protecting the lung from BLM-induced fibrosis.

SUBMITTER: Nakanishi T 

PROVIDER: S-EPMC4414486 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.

Nakanishi Takeo T   Hasegawa Yoshitaka Y   Mimura Reo R   Wakayama Tomohiko T   Uetoko Yuka Y   Komori Hisakazu H   Akanuma Shin-Ichi S   Hosoya Ken-Ichi K   Tamai Ikumi I  

PloS one 20150429 4


Prostaglandin (PG) E2 exhibits an anti-fibrotic effect in the lung in response to inflammatory reactions and is a high-affinity substrate of PG transporter (SLCO2A1). The present study aimed to evaluate the pathophysiological relevance of SLCO2A1 to bleomycin (BLM)-induced pulmonary fibrosis in mice. Immunohistochemical analysis indicated that Slco2a1 protein was expressed in airway and alveolar type I (ATI) and II (ATII) epithelial cells, and electron-microscopic immunohistochemistry further de  ...[more]

Similar Datasets

| S-EPMC5167321 | biostudies-literature
| S-EPMC7299702 | biostudies-literature
| S-EPMC9246571 | biostudies-literature
| S-EPMC6004787 | biostudies-literature
| S-EPMC3212807 | biostudies-other
| S-EPMC4634957 | biostudies-literature
| S-EPMC7652309 | biostudies-literature
| S-EPMC4488299 | biostudies-literature
| S-EPMC2753790 | biostudies-literature
| S-EPMC5659967 | biostudies-literature